Developing a new treatment for safety evaluation and clinical trials.
Official title: CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL
Funded at Albany Molecular Research, INC. · NIH-11140931 · Data updated 2026-11-12
This study is working on a new medicine called NCGC00413972 to make sure it’s safe and effective for people, with the hope that it could offer new treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | September 30, 2023 |
| Project end | September 29, 2027 |
| Funding year | 2024 |
| Award (this year) | $280,124 |
| NIH project number | 271201700005I-P00001-759502300001-1 |
| Project ID | NIH-11140931 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would include individuals with conditions that NCGC00413972 aims to address, pending successful preclinical and clinical evaluations.
✕Less likely to help
Patients who do not have the specific conditions targeted by NCGC00413972 may not receive any benefit from this research.
What this research studies
This research focuses on the development of a new compound, NCGC00413972, which involves its chemistry, manufacturing, and controls (CMC) to ensure it is safe for preclinical evaluation and future clinical trials. The project aims to establish rigorous standards and processes for the compound's production and testing, which is crucial for determining its safety and efficacy in humans. Patients may benefit from this research as it could lead to new treatment options based on the findings from the clinical trials that follow.
Why it matters
Potential benefit: If successful, this research could lead to the development of a new treatment that improves patient outcomes.
How similar studies have gone: While this approach is common in drug development, the specific compound NCGC00413972 is novel and has not been tested in clinical trials yet.
Where this research is happening
-
Albany Molecular Research, INC.
Albany, United States Active
Researchers
- Principal investigator: Penny, Brian — Albany Molecular Research, INC.
- Study coordinator: Penny, Brian
Related research
Other NIH-funded projects on the same topics.
-
Accelerating the development of new drugs for neurological conditions
This study is all about finding and creating new medicines for brain-related conditions faster, so that patients can have more treatment options that are safe and effective.
-
Developing new drugs to manage pain and substance use disorders
This study is working on new medications to help people manage pain better and tackle issues with substance use, aiming to create treatments that could improve your quality of life.
-
Improving treatments for antibiotic-resistant bacterial infections
This study is working on creating new treatments for tough infections caused by antibiotic-resistant bacteria, like Acinetobacter and Pseudomonas aeruginosa, to help patients who currently have limited options for effective care.
-
Investigating ways to improve pain management and drug formulation.
This study is all about finding better ways to manage pain by creating new and improved medications, and it’s designed for patients who are looking for effective pain relief options.
-
Developing new treatments for Alzheimer's Disease through medicinal chemistry
This study is exploring new ways to create medications for Alzheimer's Disease that could help patients by targeting the specific processes involved in the condition.
-
Developing a new treatment for safety evaluation and clinical trials.
This study is working on a new treatment called NCGC00413972 to make sure it's safe and effective for people, with the hope that it could offer new options for patients in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.